The DOI matches its Crossref record; 9 of the 10 references it cites were found in a registry or an index.
The Deciphering Developmental Disorders (DDD) study
Open accessAbstract
One of the main frustrations facing paediatric neurologists, community paediatricians, and clinical geneticists in everyday practice is the poor success rate in making accurate diagnoses for children with severe or profound neurological disability. Accurate diagnosis is the cornerstone of good medical care. However, the chance of achieving a genetic diagnosis for a child with severe developmental delay is low where no diagnosis is apparent after routine investigation – yet the majority of children with developmental disorders fall into this category. Although individually rare, collectively these conditions represent a significant burden for individuals, families, and health services.1 There has been a growing appreciation in recent years of the importance of genetic disorders in childhood neurodisability, although in many cases the location and nature of the causal mutation is unknown. In clinical practice, a family history of other similarly affected individuals is a strong pointer to a genetic aetiology, but the converse does not necessarily hold and the concept that de novo dominant mutations may cause apparently sporadic disorders is gaining acceptance. If a de novo mutation severely impairs development such that the affected individual does not reproduce, the genetic basis of their condition may remain unrecognized. Speculatively, such events may explain some cases of severe cerebral palsy or severe epileptic encephalopathy as well as severe intellectual disability. In addition, there are many undiagnosed recessively inherited neurodevelopmental disorders collectively responsible for a substantial proportion of the excess morbidity and mortality amongst infants born to consanguineous parents.2 Genomic microarray analysis has proven to be valuable for improving rates of diagnosis amongst children with developmental delay/intellectual disability caused by large structural variants (such as deletions and duplications of >50kb).3 For smaller mutations, the revolution in 'next generation' DNA sequencing technologies is now enabling genomic analysis on an unprecedented scale.4 Massively parallel sequencing enables the rapid, systematic identification of variants on a large scale, either across the whole genome or targeted at functional coding regions (the exome). This has accelerated the pace of gene discovery and disease diagnosis on a molecular level5 and may substantially improve the diagnosis of children with developmental disorders.6 The Deciphering Developmental Disorders (DDD) study is an ambitious project, combining the clinical expertise of all 23 UK NHS Regional Genetics Services with the research and bioinformatics expertise of the Wellcome Trust Sanger Institute, to undertake systematic phenotyping and detailed genomic analysis for 12 000 children with severe undiagnosed developmental disorders (Table I). This National Institute for Health Research Portfolio project is funded by the Health Innovation Challenge Fund and the Wellcome Trust Sanger Institute and began recruiting patients in April 2011 (see http://www.ddduk.org). The study will recruit 'trios', i.e. a child and both parents, and use multiple complementary genome-wide approaches – high resolution array-comparative genomic hybridization (aCGH), common variant (SNP) genotyping, and whole exome sequencing – to facilitate identification of de novo variants in the child and improve the chances of identifying relevant recessive mutations. In order to maximize the investment in detailed genomic analysis, the study uses the recently developed Human Phenotype Ontology (HPO)7 which enables comprehensive phenotypic description. The controlled vocabulary in HPO will facilitate association analysis between phenotypes and genomic variants, as well as links to other genetic studies and work in model organisms. The use of whole genome technologies in research and their translation to clinical practice raises numerous social, legal, and ethical issues, such as how to deal with findings that are incidental to the research question or clinical diagnosis.8 Embedded within the DDD project as a core activity is a programme of empirical ethical and social science research, which aims to develop strategies to gain maximum benefit from these new technologies whilst minimizing potential harm. An accurate genetic diagnosis is important for prognosis and management of affected children, and for counselling parents about the likely risk of recurrence. DDD is a translational project and it is hoped that, through the study, several thousand families will receive a genetic diagnosis for their child's developmental disorder. Furthermore, the study will facilitate better design of diagnostic assays and create an important knowledge-base for improved diagnosis of genomic disorders in the future. Analysis of OMIM statistics in April 2011 shows that entries with a phenotype description for which the molecular basis was known totalled 2993. Of an estimated 21 000 genes in
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A map of human genome variation from population-scale sequencing.
The 1000 Genomes Project Consortium (2010) · Nature · doi:10.1038/nature09534 · Cited by 7,877
DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources
Firth, H. V., Richards, S. M., Bevan, A. P., Clayton, S., Corpas, M., Rajan, D., Vooren, S. V., Moreau, Y., Pettett, R. M., & Carter, N. P. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.03.010 · Cited by 1,990
Self-citationA de novo paradigm for mental retardation.
Vissers, L. E. L. M., de Ligt, J., Gilissen, C., Janssen, I., Steehouwer, M., de Vries, P., van Lier, B., Arts, P., Wieskamp, N., del Rosario, M., et al. (2010) · Nature Genetics · doi:10.1038/ng.712 · Cited by 852
Managing Incidental Findings in Human Subjects Research: Analysis and Recommendations
Wolf, S. M., Lawrenz, F. P., Nelson, C. A., Kahn, J. P., Cho, M. K., Clayton, E. W., Fletcher, J. G., Georgieff, M., Hammerschmidt, D. E., Hudson, K., et al. (2008) · The Journal of Law Medicine & Ethics · doi:10.1111/j.1748-720x.2008.00266.x · Cited by 710
Manning, M. A., & Hudgins, L. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181f8baad · Cited by 683
Robinson, P. N., & Mundlos, S. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01436.x · Cited by 357
Massively parallel sequencing and rare disease
Ng, S. B., Nickerson, D. A., Bamshad, M. J., & Shendure, J. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq390 · Cited by 177
The impact of consanguinity on neonatal and infant health.
Bittles, A. H., & Black, M. L. (2010) · Early Human Development · doi:10.1016/j.earlhumdev.2010.08.003 · Cited by 132
Improving lives optimising resources: a vision for the UK Rare Disease Strategy
Lucas, J. S. (2011) · ePrints Soton (University of Southampton) · Cited by 13
Cited by
Sorted by citations
The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data
Köhler, S., Doelken, S., Mungall, C. J., Bauer, S., Firth, H., Bailleul-Forestier, I., Black, G., Brown, D. L., Brudno, M., Campbell, J., et al. (2013) · Nucleic Acids Res. · doi:10.1093/nar/gkt1026 · Cited by 840
Self-citationThe Human Phenotype Ontology in 2017
Köhler, S., Vasilevsky, N., Engelstad, M., Foster, E. D., McMurry, J. A., Aymé, S., Baynam, G. S., Bello, S. M., Boerkoel, C. F., Boycott, K. M., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1039 · Cited by 767
Self-citationWright, C. F., Fitzgerald, T. W., Jones, W. D., Clayton, S., McRae, J. F., van Kogelenberg, M., King, D. A., Ambridge, K., Barrett, D. M., Bayzetinova, T., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61705-0 · Cited by 753
Self-citationPaediatric genomics: diagnosing rare disease in children
Wright, C. F., FitzPatrick, D. R., & Firth, H. V. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2017.116 · Cited by 654
Self-citationThe 100 000 Genomes Project: bringing whole genome sequencing to the NHS
Turnbull, C., Scott, R. H., Thomas, E. R. A., Jones, J. L., Murugaesu, N., Boardman-Pretty, F., Halai, D., Baple, E. L., Craig, C. E. H., Hamblin, A. D., et al. (2018) · BMJ · doi:10.1136/bmj.k1687 · Cited by 436
Neurodevelopmental disease genes implicated by de novo mutation and copy number variation morbidity
Coe, B. P., Stessman, H. A. F., Sulovari, A., Geisheker, M. R., Bakken, T. E., Lake, A. M., Dougherty, J. D., Lein, E. S., Hormozdiari, F., Bernier, R. A., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0288-4 · Cited by 330
A guide for the diagnosis of rare and undiagnosed disease: beyond the exome
Marwaha, S., Knowles, J. W., & Ashley, E. A. (2022) · Genome Medicine · doi:10.1186/s13073-022-01026-w · Cited by 400
The European Genome-phenome Archive of human data consented for biomedical research
Lappalainen, I., Almeida, J. P., Kumanduri, V., Senf, A., Spalding, D., Ur-Rehman, S., Saunders, G. I., Kandasamy, J., Cáccamo, M., Leinonen, R., et al. (2015) · Nature Genetics · doi:10.1038/ng.3312 · Cited by 366
Bragin, E., Chatzimichali, E. A., Wright, C. F., Hurles, M. E., Firth, H. V., Bevan, A. P., & Swaminathan, G. J. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt937 · Cited by 233
Self-citationInsights into genetics, human biology and disease gleaned from family based genomic studies
Posey, J. E., O’Donnell‐Luria, A., Chong, J. X., Harel, T., Jhangiani, S. N., Coban‐Akdemir, Z., Buyske, S. G., Pehli̇van, D., Carvalho, C. M. B., Baxter, S. M., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-018-0408-7 · Cited by 202
Flexible and scalable diagnostic filtering of genomic variants using G2P with Ensembl VEP
Thormann, A., Halachev, M., McLaren, W., Moore, D. J., Svinti, V., Campbell, A., Kerr, S. M., Tischkowitz, M., Hunt, S. E., Dunlop, M. G., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10016-3 · Cited by 151
Self-citationAnsari, M., Poke, G., Ferry, Q. R. V., Williamson, K. A., Aldridge, R. C. L., Meynert, A. M., Bengani, H., Chan, C. Y., Kayserili, H., Avcı, Ş., et al. (2014) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2014-102573 · Cited by 164
Self-citationBCL11A Haploinsufficiency Causes an Intellectual Disability Syndrome and Dysregulates Transcription
Dias, C., Estruch, S. B., Graham, S. A., McRae, J. F., Sawiak, S. J., Hurst, J. A., Joss, S. K., Holder, S., Morton, J. E. V., Turner, C., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.05.030 · Cited by 168
Spatiotemporal transcriptomic atlas of mouse organogenesis using DNA nanoball-patterned arrays.
Chen, A., Liao, S., Cheng, M., Ma, K., Wu, L. L., Lai, Y., Qiu, X., Yang, J., Xu, J., Hao, S., et al. (2022) · Apollo (University of Cambridge) · Cited by 154
Weiss, K., Terhal, P. A., Cohen, L., Bruccoleri, M., Irving, M. D., Martinez, A. F., Rosenfeld, J. A., Machol, K., Yang, Y., Liu, P., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.08.001 · Cited by 139
Homozygous and hemizygous CNV detection from exome sequencing data in a Mendelian disease cohort
Gambin, T., Coban‐Akdemir, Z., Yuan, B., Gu, S., Chiang, T., Carvalho, C. M. B., Shaw, C. A., Jhangiani, S. N., Boone, P. M., Eldomery, M. K., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1237 · Cited by 123
Westbury, S. K., Turro, E., Greene, D. J., Lentaigne, C., Kelly, A. M., Bariana, T. K., Simeoni, I., Pillois, X., Attwood, A., Austin, S. K., et al. (2015) · Genome Medicine · doi:10.1186/s13073-015-0151-5 · Cited by 124
Gasc, C., Peyretaillade, É., & Peyret, P. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw309 · Cited by 119
Molecular Genetics and Complex Inheritance of Congenital Heart Disease
Diab, N. S., Barish, S., Dong, W., Zhao, S., Allington, G., Yu, X., Kahle, K. T., Brueckner, M. K., & Jin, S. C. (2021) · Genes · doi:10.3390/genes12071020 · Cited by 114
Systematic discovery of protein interaction interfaces using AlphaFold and experimental validation
Lee, C. Y., Hubrich, D., Varga, J. K., Schäfer, C., Welzel, M., Schumbera, E., Djokic, M., Strom, J. M., Schönfeld, J., Geist, J. L., et al. (2024) · Molecular Systems Biology · doi:10.1038/s44320-023-00005-6 · Cited by 105
“A list of NDD genes was assembled using whole exome and whole genome sequencing studies of cohorts of NDD patients from Gene4Denovo (Zhao et al, 2020) and Deciphering Developmental Disorders (DDD) study (Firth et al, 2011), respectively.”
Systematic discovery of protein interaction interfaces using AlphaFold and experimental validation
Lee, C. Y., Hubrich, D., Varga, J. K., Schäfer, C., Welzel, M., Schumbera, E., Đokić, M., Strom, J. M., Schönfeld, J., Geist, J. L., et al. (2023) · doi:10.1101/2023.08.07.552219 · Cited by 105
Japan’s initiative on rare and undiagnosed diseases (IRUD): towards an end to the diagnostic odyssey
Adachi, T., Kawamura, K., Furusawa, Y., Nishizaki, Y., Imanishi, N., Umehara, S., Izumi, K., & Suematsu, M. (2017) · European Journal of Human Genetics · doi:10.1038/ejhg.2017.106 · Cited by 103
McEntagart, M., Williamson, K. A., Rainger, J. K., Wheeler, A. P., Seawright, A., Baere, E. B. W. D., Verdin, H., Bergendahl, L. T., Quigley, A. J., Rainger, J., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.03.018 · Cited by 101
King, D. A., Fitzgerald, T. W., Miller, R., Canham, N. L. E., Clayton‐Smith, J., Johnson, D. S., Mansour, S., Stewart, F., Vasudevan, P. C., Hurles, M. E., et al. (2013) · Genome Research · doi:10.1101/gr.160465.113 · Cited by 94
Wright, C. F., Prigmore, E., Rajan, D., Handsaker, J., McRae, J. F., Kaplanis, J., Fitzgerald, T. W., FitzPatrick, D. R., Firth, H. V., & Hurles, M. E. (2019) · Nature Communications · doi:10.1038/s41467-019-11059-2 · Cited by 90
Self-citationGeoffroy, V., Guignard, T., Kress, A., Gaillard, J., Solli-Nowlan, T., Schalk, A., Gâtinois, V., Dollfus, H., Scheidecker, S., & Muller, J. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab402 · Cited by 87
Catalytic deficiency of O-GlcNAc transferase leads to X-linked intellectual disability
Pravatà, V. M., Muha, V., Gundogdu, M., Ferenbach, A. T., Kakade, P. S., Vandadi, V., Wilmes, A. C., Borodkin, V. S., Joss, S. K., Stavridis, M. P., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1900065116 · Cited by 88
Swaminathan, G. J., Bragin, E., Chatzimichali, E., Corpas, M., Bevan, A. P., Wright, C. F., Carter, N. P., Hurles, M. E., & Firth, H. V. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds362 · Cited by 79
Self-citationSpatiotemporal transcriptomic atlas of mouse organogenesis using DNA nanoball patterned arraysPreprint
Chen, A., Liao, S., Cheng, M., Ma, K., Wu, L., Lai, Y., Qiu, X., Yang, J., Li, W., Xu, J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.17.427004 · Cited by 78
The Growing Importance of CNVs: New Insights for Detection and Clinical Interpretation
Valsesia, A., Macé, A., Jacquemont, S., Beckmann, J. S., & Kutalik, Z. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00092 · Cited by 78
Hamilton, M., Newbury-Ecob, R. A., Holder‐Espinasse, M., Yau, S., Lillis, S., Hurst, J. A., Clement, E. M., Reardon, W., Joss, S. K., Hobson, E., et al. (2016) · Clinical Dysmorphology · doi:10.1097/mcd.0000000000000143 · Cited by 75
Johnson, J. L., Stoica, L., Liu, Y., Zhu, P., Bhattacharya, A., Buffington, S. A., Huq, R., Eissa, N. T., Larsson, O. S., Porse, B. T., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.08.027 · Cited by 80
De Novo Mutations in EBF3 Cause a Neurodevelopmental Syndrome
Sleven, H., Welsh, S. J., Yu, J., Churchill, M. E. A., Wright, C. F., Henderson, A., Horváth, R., Rankin, J., Vogt, J., Magee, A. C., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.11.020 · Cited by 71
Self-citationVialle, R. A., Lopes, K. D. P., Bennett, D. A., Crary, J. F., & Raj, T. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01031-7 · Cited by 64
Further delineation of the KAT6B molecular and phenotypic spectrum
study, D., Gannon, T., Perveen, R., Schlecht, H., Ramsden, S., Anderson, B., Kerr, B. A., Day, R., Banka, S., Suri, M., et al. (2014) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.248 · Cited by 65
Franco, E. D., Watson, R. A., Weninger, W. J., Wong, C. C., Flanagan, S. E., Caswell, R. C., Green, A., Tudor, C. L., Lelliott, C. J., Geyer, S. H., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.03.018 · Cited by 64
Saturation genome editing of DDX3X clarifies pathogenicity of germline and somatic variation
Radford, E. J., Tan, H.-K., Andersson, M. H. L., Stephenson, J. D., Gardner, E. J., Ironfield, H., Waters, A. J., Gitterman, D. P., Lindsay, S., Abascal, F., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43041-4 · Cited by 63
Self-citationGuo, H., Bettella, E., Marcogliese, P. C., Zhao, R., Andrews, J. C., Nowakowski, T. J., Gillentine, M. A., Hoekzema, K., Wang, T., Wu, H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12435-8 · Cited by 64
Pravatà, V. M., Gundogdu, M., Bartual, S. G., Ferenbach, A. T., Stavridis, M. P., Õunap, K., Pajusalu, S., Žordania, R., Wojcik, M. H., & van Aalten, D. M. F. (2019) · FEBS Letters · doi:10.1002/1873-3468.13640 · Cited by 61
Mosaic structural variation in children with developmental disorders
King, D. A., Jones, W. D., Crow, Y. J., Dominiczak, A. F., Foster, N. A., Gaunt, T. R., Harris, J., Hellens, S. W., Homfray, T., Innes, J., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv033 · Cited by 61
Encephalopathies with KCNC1 variants: genotype‐phenotype‐functional correlations
Cameron, J. M., Maljevic, S., Nair, U., Aung, Y. H., Cogné, B., Bezieau, S., Blair, E. M., Isidor, B., Zweier, C., Reis, A., et al. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.50822 · Cited by 57
Using Drosophila to drive the diagnosis and understand the mechanisms of rare human diseases
Link, N., & Bellen, H. J. (2020) · Development · doi:10.1242/dev.191411 · Cited by 52
Ostrowski, P. J., Zachariou, A., Loveday, C., Beleza‐Meireles, A., Bértoli, M., Dean, J., Douglas, A. G. L., Ellis, I., Foster, A. C., Graham, J. M., et al. (2019) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31749 · Cited by 55
A framework to score the effects of structural variants in health and diseasePreprint
Kleinert, P., & Kircher, M. (2022) · Genome Research · doi:10.1101/gr.275995.121 · Cited by 62
Detection of structural mosaicism from targeted and whole-genome sequencing dataPreprint
King, D. A., Sifrim, A., Fitzgerald, T. W., Rahbari, R., Hobson, E., Homfray, T., Mansour, S., Mehta, S. G., Shehla, M., Tomkins, S. E., et al. (2017) · Genome Research · doi:10.1101/gr.212373.116 · Cited by 58
Cafferkey, M., Ahn, J. W., Flinter, F., & Ogilvie, C. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36554 · Cited by 92
The clinical presentation caused by truncating CHD8 variants
Douzgou, S., Liang, H. W., Metcalfe, K., Somarathi, S., Tischkowitz, M., Mohamed, W., Kini, U., McKee, S., Yates, L., Bertoli, M., et al. (2019) · Clinical Genetics · doi:10.1111/cge.13554 · Cited by 52
AI-MARRVEL — A Knowledge-Driven AI System for Diagnosing Mendelian Disorders
Mao, D., Liu, C., Wang, L., AI-Ouran, R., Deisseroth, C., Pasupuleti, S., Kim, S. Y., Li, L., Rosenfeld, J. A., Meng, L., et al. (2024) · NEJM AI · doi:10.1056/aioa2300009 · Cited by 51
Weiss, K., Wigby, K. M., Fannemel, M., Henderson, L. B., Beck, N. M., Ghali, N., Study, D. D. D., Anderlid, B., Lundin, J., Hamosh, A., et al. (2017) · European Journal of Human Genetics · doi:10.1038/ejhg.2017.86 · Cited by 47
Genome annotation for clinical genomic diagnostics: strengths and weaknesses
Steward, C. A., Parker, A. P. J., Minassian, B. A., Sisodiya, S. M., Frankish, A., & Harrow, J. (2017) · Genome Medicine · doi:10.1186/s13073-017-0441-1 · Cited by 51
Birnbaum, R., Mahjani, B., Loos, R. J. F., & Sharp, A. J. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.4080 · Cited by 48
Novel bioinformatic developments for exome sequencing
Lelieveld, S. H., Veltman, J. A., & Gilissen, C. (2016) · Human Genetics · doi:10.1007/s00439-016-1658-6 · Cited by 46
Hamilton, M. J., Caswell, R. C., Canham, N., Cole, T., Firth, H. V., Foulds, N., Heimdal, K., Hobson, E., Houge, G., Joss, S., et al. (2018) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2017-104620 · Cited by 43
Self-citationStrategies to Uplift Novel Mendelian Gene Discovery for Improved Clinical Outcomes
Seaby, E. G., Rehm, H. L., & O’Donnell‐Luria, A. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.674295 · Cited by 41
Owen, C. I., Bowden, A. R., Parker, M. J., Patterson, J., Patterson, J., Price, S., Sarkar, A., Castle, B., Deshpande, C., Splitt, M. P., et al. (2018) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38610 · Cited by 40
Few shot learning for phenotype-driven diagnosis of patients with rare genetic diseases
Alsentzer, E., Li, M. M., Kobren, S. N., Noori, A., Undiagnosed Diseases Network, Kohane, I. S., & Zitnik, M. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01749-1 · Cited by 54
A Refined Approach to Evaluating Global Developmental Delay for the International Medical Community
Jiménez-Gómez, A., & Standridge, S. M. (2014) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2013.12.018 · Cited by 34
Hamilton, M., & Suri, M. (2018) · Advances in genetics · doi:10.1016/bs.adgen.2018.11.001 · Cited by 30
De novo variants in CNOT3 cause a variable neurodevelopmental disorder
Martin, R., Splitt, M. P., Geneviève, D., Aten, E., Collins, A. R., de Bie, C. I., Faivre, L. O., Foulds, N. C., Giltay, J. C., Ibitoye, R., et al. (2019) · European Journal of Human Genetics · doi:10.1038/s41431-019-0413-6 · Cited by 30
Sugiki, T., Egawa, D., Kumagai, K., Kojima, C., Fujiwara, T., Takeuchi, K., Shimada, I., Hanada, K., & Takahashi, H. K. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002465 · Cited by 32
Bayat, A., Knaus, A., Juul, A. W., Đukić, D., Gardella, E., Charzewska, A., Clement, E. M., Hjalgrim, H., Hoffman‐Zacharska, D., Horn, D., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-019-0512-3 · Cited by 28
Gerrard, D. T., Berry, A. A., Jennings, R. E., Birket, M. J., Zarrineh, P., Garstang, M. G., Withey, S., Short, P., Jiménez-Gancedo, S., Firbas, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17305-2 · Cited by 28
Lahm, H., Schön, P., Doppler, S. A., Dreßen, M., Cleuziou, J., Deutsch, M.-A., Ewert, P., Lange, R., & Krane, M. (2015) · Current Genomics · doi:10.2174/1389202916666150303232520 · Cited by 28
Computational analysis of neurodevelopmental phenotypes: Harmonization empowers clinical discovery
Lewis‐Smith, D., Parthasarathy, S., Xian, J., Kaufman, M. C., Ganesan, S., Galer, P. D., Thomas, R. H., & Helbig, I. (2022) · Human Mutation · doi:10.1002/humu.24389 · Cited by 21
Atypical face shape and genomic structural variants in epilepsy
Chinthapalli, K., Bartolini, E., Nový, J., Suttie, M., Marini, C., Falchi, M., Fox, Z. V., Clayton, L. M. S., Sander, J. W. A. S., Guerrini, R., et al. (2012) · Brain · doi:10.1093/brain/aws232 · Cited by 26
Exome Sequencing in Fetuses with Structural Malformations
Mackie, F. L., Carss, K., Hillman, S., Hurles, M. E., & Kilby, M. D. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3030747 · Cited by 25
In vitro screening of embryos by whole-genome sequencing: now, in the future or never?
Winand, R., Hens, K., Dondorp, W., de Wert, G. M. W. R., Moreau, Y., Vermeesch, J. R., Liebaers, I., & Aerts, J. A. (2014) · Human Reproduction · doi:10.1093/humrep/deu005 · Cited by 25
Study, O. B. O. T. D., Middleton, A., Bragin, E., & Parker, M. J. (2014) · Journal of Community Genetics · doi:10.1007/s12687-014-0184-2 · Cited by 25
Schirwani, S., Albaba, S., Carere, D. A., Sacoto, M. J. G., Zamora, F. M., Si, Y. C., Rabin, R., Pappas, J., Renaud, D. L., Hauser, N., et al. (2021) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62465 · Cited by 25
Omelková, M., Fenger, C., Murray, M., Hammer, T. B., Pravatà, V. M., Bartual, S. G., Czajewski, I., Bayat, A., Ferenbach, A. T., Stavridis, M. P., et al. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.049132 · Cited by 25
Samarakoon, P. S., Sorte, H. S., Stray‐Pedersen, A., Rødningen, O. K., Rognes, T., & Lyle, R. (2016) · BMC Genomics · doi:10.1186/s12864-016-2374-2 · Cited by 28
Dorn, C., Grunert, M., & Sperling, S. (2013) · Briefings in Functional Genomics · doi:10.1093/bfgp/elt040 · Cited by 23
Zahir, F., Mwenifumbo, J. C., Chun, H.-J. E., Lim, E. L., van Karnebeek, C., Couse, M., Mungall, K. L., Lee, L., Makela, N., Armstrong, L., et al. (2017) · BMC Genomics · doi:10.1186/s12864-017-3671-0 · Cited by 25
Jones, G. E., Johnson, K. E., Eason, J., Hamilton, M., Osio, D., Kanani, F., Baptista, J., & Suri, M. (2022) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2022.104572 · Cited by 23
Middleton, A., Bragin, E., Morley, K. I., & Parker, M. J. (2013) · Social Science Research · doi:10.1016/j.ssresearch.2013.12.004 · Cited by 23
Meyer, R., Begemann, M., Demuth, S., Kraft, F., Dey, D., Schüler, H. M., Busse, S., Häusler, M., Zerres, K., Kurth, I., et al. (2020) · Clinical Genetics · doi:10.1111/cge.13819 · Cited by 23
Lewis, C., Hammond, J., Hill, M. K., Searle, B. A., Hunter, A., Patch, C., Chitty, L. S., & Sanderson, S. C. (2020) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2020.104043 · Cited by 23
Seaby, E. G., Smedley, D. P., Tavares, A. L. T., Brittain, H. K., van Jaarsveld, R. H., Baralle, D., Rehm, H. L., O’Donnell‐Luria, A., & Ennis, S. (2022) · Genetics in Medicine · doi:10.1016/j.gim.2022.04.019 · Cited by 23
Senarathne, U. D., Indika, N.-L. R., Jezela‐Stanek, A., Ciara, E., Frye, R. E., Chen, C., & Stępień, K. M. (2023) · Genes · doi:10.3390/genes14040803 · Cited by 25
Zucca, S., Nicora, G., Paoli, F. D., Carta, M. G., Bellazzi, R., Magni, P., Rizzo, E., & Limongelli, I. (2024) · Human Genetics · doi:10.1007/s00439-023-02638-x · Cited by 25
Transcriptome-wide outlier approach identifies individuals with minor spliceopathies
Maurer, T. M., Mendez, R., Ungar, R. A., Bonner, D. E., Matalon, D. R., Lemire, G., Goddard, P. C., Padhi, E. M., Miller, A. M., Nguyen, J., et al. (2025) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2025.08.018 · Cited by 26
Genome sequencing data analysis for rare disease gene discovery
Umlai, U. I., Bangarusamy, D. K., Estivill, X., & Jithesh, P. V. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab363 · Cited by 20
Empirical research on the ethics of genomic research
Middleton, A., Parker, M. J., Wright, C. F., Bragin, E., Hurles, M. E., & Study, O. B. O. T. D. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36067 · Cited by 19
Self-citationDiquigiovanni, C., Bergamini, C., Diaz, R., Liparulo, I., Bianco, F., Masin, L., Baldassarro, V. A., Rizzardi, N., Tranchina, A., Buscherini, F., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201802722r · Cited by 20
Enabling Global Clinical Collaborations on Identifiable Patient Data: The Minerva Initiative
Nellåker, C., Alkuraya, F. S., Baynam, G. S., Bernier, R., Bernier, F. P., Boulanger, V. M., Brudno, M., Brunner, H. G., Clayton‐Smith, J., Cogné, B., et al. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00611 · Cited by 19
Self-citation1q24 deletion syndrome. Two cases and new insights into genotype‐phenotype correlations
Lefroy, H., Fox, O., Javaid, M. K., Makaya, T., & Shears, D. J. (2018) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.40426 · Cited by 18
Pathogenic KDM5B variants in the context of developmental disorders
Harrington, J., Wheway, G., Willaime‐Morawek, S., Gibson, J., & Walters, Z. S. (2022) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2022.194848 · Cited by 19
Abbott, M., McKenzie, L. C., Morán, B. V. G., Heidenreich, S., Hernández, R. A., Hocking, L. J., Clark, C., Gomes, J., Lampe, A., Baty, D. U., et al. (2021) · Journal of Community Genetics · doi:10.1007/s12687-021-00541-4 · Cited by 17
Automated prediction of the clinical impact of structural copy number variations
Gažiová, M., Sládeček, T., Pös, O., Stevko, M., Krampl, W., Pös, Z., Hekel, R., Hlavacka, M., Kucharík, M., Radvánszky, J., et al. (2022) · Scientific Reports · doi:10.1038/s41598-021-04505-z · Cited by 16
Darvish, H., Azcona, L. J., Tafakhori, A., Mesias, R., Ahmadifard, A., Sánchez, E., Habibi, A., Alehabib, E., Johari, A. H., Emamalizadeh, B., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-57929-4 · Cited by 17
PheNominal: an EHR-integrated web application for structured deep phenotyping at the point of care
Havrilla, J. M., Singaravelu, A., Driscoll, D. M., Minkovsky, L., Helbig, I., Medne, L., Wang, K., Krantz, I. D., & Desai, B. R. (2022) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-022-01927-1 · Cited by 15
Mary, L., Nourisson, E., Feger, C., Laugel, V., Chaigne, D., Keren, B., Afenjar, A., de Villemeur, T. B., Trost, D., Cieuta‐Walti, C., et al. (2021) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62181 · Cited by 16
Interpretation of Genomic Copy Number Variants Using DECIPHER
Corpas, M., Bragin, E., Clayton, S., Bevan, A. P., & Firth, H. V. (2012) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg0814s72 · Cited by 15
Self-citationMolecular mechanisms of β-cell dysfunction and death in monogenic forms of diabetes
Caballero, L. S., Gorgogietas, V. A., Arroyo, M. N., & Igoillo‐Esteve, M. (2021) · International review of cytology · doi:10.1016/bs.ircmb.2021.02.005 · Cited by 16
The GA4GH Phenopacket schema: A computable representation of clinical data for precision medicinePreprint
Jacobsen, J. O. B., Baudis, M., Baynam, G. S., Beckmann, J. S., Beltrán, S., Callahan, T. J., Chute, C. G., Courtot, M., Daniš, D., Elemento, O., et al. (2021) · medRxiv · doi:10.1101/2021.11.27.21266944 · Cited by 15
Copeland, H., Kivuva, E. C., Firth, H. V., & Wright, C. F. (2021) · Genetics in Medicine · doi:10.1038/s41436-021-01110-3 · Cited by 18
Self-citationGurasashvili, J., Silverio, S. A., Hill, M., Peter, M., Stafford‐Smith, B., & Lewis, C. (2024) · Journal of Genetic Counseling · doi:10.1002/jgc4.1818 · Cited by 13
Loong, L., Tardivo, A., Knaus, A., Hashim, M., Pagnamenta, A. T., Alt, K., Böhrer‐Rabel, H., Caro‐Llopis, A., Cole, T. R. P., Distelmaier, F., et al. (2022) · Genetics in Medicine · doi:10.1016/j.gim.2022.09.007 · Cited by 14
Genomics and Patient Empowerment
McAllister, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-420195-8.00003-3 · Cited by 13
Clinical and Neurobiological Aspects of TAO Kinase Family in Neurodevelopmental Disorders
Hu, C., Feng, P., Yang, Q., & Xiao, L. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.655037 · Cited by 13
Metadata
- Authors
- FIRTH, H. V., WRIGHT, C. F., & Study, F. T. D.
- Affiliations
- Cambridge University Hospitals NHS Foundation Trust (GB)
- Wellcome Sanger Institute (GB)
- Venue
- Developmental Medicine & Child Neurology
- Publisher
- Wiley
- Published
- 2011-06-17
- Volume
- 53
- Issue
- 8
- Pages
- 702-703
- ISSN
- 0012-1622 (ISSN-L)
- OpenAlex
- W2055032549
- Cited by
- 180
- References
- 10
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 11 · 2023: 15 · 2022: 22 · 2021: 23 · 2020: 10 · 2019: 21 · 2018: 15 · 2017: 10 · 2016: 11 · 2015: 8 · 2014: 9 · 2013: 8 · 2012: 4
- FWCI
- 4.13
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Developmental Medicine & Child Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- National Institute for Health and Care Research
- University of Cambridge
- Cambridge University Hospitals
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- genetic diagnosis, intellectual disability, de novo mutations, recessive inheritance, consanguinity, structural variants, genomic microarrays, exome sequencing, whole genome sequencing, phenotyping, rare variants, pediatric neurology, medical genetics
- MeSH terms
- Child, Developmental Disabilities, Disability Evaluation, Genetic Testing, United Kingdom, Humans, Computational Biology, Genetic Predisposition to Disease, Genomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
